Tesamorelin | 10mg

Name: Tesamorelin Vial | 10mg
Brand: Vytol
Price: 50.00 GBP
Availability: InStock

Tesamorelin 10mg research solution, precisely dosed and independently verified by Janoshik Analytical. A synthetic peptide studied in published laboratory research as a growth hormone-releasing hormone (GHRH) analogue, with research interest in its role in GH/IGF-1 secretion pathways and body composition research models. For research purposes only.

Unlock an instant 10% off

Enter your email to get an instant 10% off your order

Your discount code

VIAL10

Apply this code at checkout to get your discount

Meet the Tesamorelin Vial

Ready-to-use research solution
≥99% purity, third-party verified
Pharmaceutical grade research formulation
Free shipping on all UK orders

Tesamorelin | A synthetic peptide analogue of growth hormone-releasing hormone (GHRH), studied extensively in experimental and preclinical research for its role in growth hormone and IGF-1 secretion pathways. Frequently explored in laboratory models focused on body composition, lipid metabolism, and endocrine research due to its interaction with the somatotropic axis.

Our compounds are manufactured by Homopeptides and every batch is independently analysed by Janoshik Analytical before reaching you. Janoshik are one of the most respected third-party testing laboratories in the peptide research space — their verification gives you confidence in every order.

Download Certificate of Analysis

This compound is supplied as a lyophilized (freeze-dried) powder and has not been reconstituted. Store immediately upon receipt at 2–8°C in a refrigerator, or at −20°C for long-term storage. Do not expose to room temperature for extended periods prior to use. Keep away from direct light and heat sources.

Once reconstituted with bacteriostatic water (BAC water), the resulting solution should be stored at 4°C and typically remains stable for 4–6 weeks, though stability may vary depending on storage conditions and handling. Discard if any cloudiness, discolouration or particulate matter is observed at any stage.

All orders are dispatched within 1–2 business days. Compounds are packaged with temperature-controlled materials to maintain integrity during transit. Free shipping on all UK orders.

tesa.

clinical research has demonstrated significant reductions in visceral abdominal fat and waist circumference in research use*

Browse catalogue

*Based on published peer-reviewed clinical research. Falutz J et al. J Acquir Immune Defic Syndr. 2010;53(3):311–322. Falutz J et al. J Clin Endocrinol Metab. 2010;95(9):4291–4304. Stanley TL et al. JAMA. 2014;312(4):380–389. Studies were conducted primarily in adults with HIV-associated abdominal fat accumulation. For research purposes only. Not for human use. Findings should not be extrapolated to other populations.

Compounds built for
precision

reduction in visceral abdominal fat observed after 26 weeks in a randomized, placebo-controlled clinical trial.*

net reduction in visceral adipose tissue versus placebo observed in a 12-month randomized controlled study.**

*Based on published peer-reviewed clinical research. Falutz J et al. N Engl J Med. 2007;357:2359–2370. Visceral adipose tissue decreased 15.2% in the tesamorelin group versus a 5.0% increase with placebo after 26 weeks. **Based on published peer-reviewed clinical research. Stanley TL et al. J Clin Endocrinol Metab. 2012;97(12):4769–4778. A 19% net treatment effect on visceral adipose tissue versus placebo was reported over 12 months. Study populations and outcomes varied. For research purposes only. Not for human use. Findings should not be extrapolated beyond the studied populations.